AdvaMed Joins Global Coalition to Promote Patient Access to Radiotherapy
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) has joined with several groups representing medical professionals, advocacy groups, international societies and the health care industry to form The Global Coalition for Radiotherapy (TGCR) to ensure cancer patients have access to this vital therapy during the COVID-19 pandemic and beyond.
“As health care systems around the world are being strained to the breaking point due to COVID-19, and surgeries and chemotherapy sessions are being cancelled, access to radiotherapy is becoming more and more crucial to patients battling cancer,” said Shandi Barney, Vice President, Radiation Therapy, AdvaMed. “This Coalition brings together expert groups from across the health care spectrum to develop policies and best practices so that patients will continue to benefit from this life-saving treatment during and after the current crisis.”
The Global Coalition for Radiotherapy will serve as a collective multidisciplinary voice, advocating on behalf of patients who depend on radiotherapy. The group will leverage and share the existing work of its individual members from around the world and recommend best practices and policies focused on what is needed to further promote radiotherapy now and in a post-COVID-19 world.
Joining AdvaMed in the Coalition are Action Radiotherapy, COCIR, City Cancer Challenge,and AAPM (the American Association of Physicists in Medicine), among others. For further information, visit the Coalition’s web site.
AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.